COVID-19 and COVID-19 vaccinations lead to serological responses in patients with inflammatory bowel diseases independent of the type of immunomodulatory medication
Background/Objectives: The COVID-19 pandemic and the development of vaccines provided the opportunity to monitor disease prevalence and outcomes, vacc...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
26 August 2025
|
| In: |
Biomedicines
Year: 2025, Volume: 13, Issue: 9, Pages: 1-14 |
| ISSN: | 2227-9059 |
| DOI: | 10.3390/biomedicines13092072 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.3390/biomedicines13092072 Verlag, kostenfrei, Volltext: https://www.mdpi.com/2227-9059/13/9/2072 
|
| Author Notes: | Larissa Kunoff, Martin Kreysing, and Annika Gauss |
| Summary: | Background/Objectives: The COVID-19 pandemic and the development of vaccines provided the opportunity to monitor disease prevalence and outcomes, vacc... |
|---|---|
| Item Description: | Online veröffentlicht am 26. August 2025 Gesehen am 16.01.2026 |
| Physical Description: | Online Resource |
| ISSN: | 2227-9059 |
| DOI: | 10.3390/biomedicines13092072 |